Interaction analysis of various inhibitors with center n mutants of the mitochondrial cytochrome b.
Brasseur
G
G
Unité de Métabolisme Energétique-LCB, B.P. N.3, Marseille, France.
Brivet-Chevillotte
P
P
D000880:Anthraquinones / Q000378:metabolism / Q000494:pharmacology; D000935:Antifungal Agents / Q000378:metabolism / Q000494:pharmacology; D000968:Antimycin A / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D003573:Cytochrome b Group / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*; D004237:Diuron / Q000378:metabolism* / Q000494:pharmacology; D016368:Frameshift Mutation; D006912:Hydroxyquinolines / Q000378:metabolism* / Q000494:pharmacology; D008928:Mitochondria / Q000378:metabolism*; D017354:Point Mutation; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism; D012441:Saccharomyces cerevisiae / Q000378:metabolism; D013053:Spectrophotometry
D000880:Anthraquinones; D000935:Antifungal Agents; D003573:Cytochrome b Group; D006912:Hydroxyquinolines; D011994:Recombinant Proteins; C032456:antimycin; C001333:2-(n-heptyl)-4-hydroxyquinoline N-oxide; C015286:funiculosin (anthraquinone); D000968:Antimycin A; D004237:Diuron